Perspective Therapeutics (CATX) Short Interest Ratio & Short Volume → Trump’s last act as President (From Porter & Company) (Ad) Free CATX Stock Alerts 1.68 +0.04 (+2.44%) (As of 04:10 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipShort InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipShort Interest Perspective Therapeutics Short Interest DataCurrent Short Volume10,430,000 sharesPrevious Short Volume8,090,000 sharesChange Vs. Previous Month+28.92%Dollar Volume Sold Short$0.00Short Interest Ratio / Days to Cover2.6Last Record DateApril 15, 2024Outstanding Shares586,920,000 sharesFloat Size466,310,000 sharesShort Percent of Float2.24%Today's Trading Volume4,218,501 sharesAverage Trading Volume3,872,213 sharesToday's Volume Vs. Average109% Short Selling Perspective Therapeutics ? Sign up to receive the latest short interest report for Perspective Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCATX Short Interest Over TimeCATX Days to Cover Over TimeCATX Percentage of Float Shorted Over Time Ad Banyan Hill PublishingREAD THIS – If You Missed Out On The AI BoomAdam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”Click on Adam's shiny forehead for more details. Perspective Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202410,430,000 shares $0.00 +28.9%2.2%2.6 $0.00 3/31/20248,090,000 shares $0.00 +330.3%2.1%2.6 $0.00 3/15/20241,880,000 shares $0.00 +0.5%0.5%0.7 $0.00 2/29/20241,870,000 shares $0.00 -37.9%0.6%0.8 $0.00 2/15/20243,010,000 shares $0.00 +46.8%0.8%1.7 $0.00 1/31/20242,050,000 shares $0.00 +6.2%0.8%1.3 $0.00 Get the Latest News and Ratings for CATX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Perspective Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/20241,930,000 shares $0.00 No Change1.0%2 $0.00 12/31/20231,930,000 shares $0.00 +6.6%1.0%2.6 $0.00 12/15/20231,810,000 shares $0.00 -1.6%0.9%4.5 $0.00 11/30/20231,840,000 shares $0.00 -4.7%0.9%1.9 $0.00 11/15/20231,930,000 shares $0.00 -5.9%1.0%2 $0.00 10/31/20232,050,000 shares $0.00 +6.2%1.0%2.1 $0.00 10/15/20231,930,000 shares $0.00 -4.9%1.0%1.9 $0.00 9/30/20232,030,000 shares $0.00 +28.5%1.0%2.1 $0.00 9/15/20231,580,000 shares $0.00 +0.6%0.8%1.7 $0.00 8/31/20231,570,000 shares $0.00 -11.8%0.8%5.2 $0.00 8/15/20231,780,000 shares $0.00 +5.3%0.6%6 $0.00 7/31/20231,690,000 shares $0.00 +3.1%0.6%5.3 $0.00 7/15/20231,640,000 shares $0.00 -3.5%0.6%4.5 $0.00 6/30/20231,700,000 shares $0.00 +9.0%0.6%4.2 $0.00 6/15/20231,560,000 shares $0.00 -12.9%0.6%3.5 $0.00 5/31/20231,790,000 shares $0.00 -6.8%0.6%2.7 $0.00 5/15/20231,920,000 shares $0.00 No Change0.7%2.9 $0.00 CATX Short Interest - Frequently Asked Questions What is Perspective Therapeutics' current short interest? Short interest is the volume of Perspective Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 10,430,000 shares of CATX short. 2.24% of Perspective Therapeutics' shares are currently sold short. Learn More on Perspective Therapeutics' current short interest. What is a good short interest ratio for Perspective Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CATX shares currently have a short interest ratio of 3.0. Learn More on Perspective Therapeutics's short interest ratio. What is a good short interest percentage for Perspective Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.24% of Perspective Therapeutics' floating shares are currently sold short. Is Perspective Therapeutics' short interest increasing or decreasing? Perspective Therapeutics saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 10,430,000 shares, an increase of 28.9% from the previous total of 8,090,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Perspective Therapeutics' float size? Perspective Therapeutics currently has issued a total of 586,920,000 shares. Some of Perspective Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Perspective Therapeutics currently has a public float of 466,310,000 shares. How does Perspective Therapeutics' short interest compare to its competitors? 2.24% of Perspective Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "surgical & medical instruments" compare to Perspective Therapeutics: MiMedx Group, Inc. (3.73%), Artivion, Inc. (7.16%), Paragon 28, Inc. (9.33%), OrthoPediatrics Corp. (6.10%), Atrion Co. (8.72%), AtriCure, Inc. (6.61%), Treace Medical Concepts, Inc. (6.39%), Silk Road Medical, Inc (10.57%), SI-BONE, Inc. (6.31%), Embecta Corp. (4.60%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Perspective Therapeutics stock? Short selling CATX is an investing strategy that aims to generate trading profit from Perspective Therapeutics as its price is falling. CATX shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Perspective Therapeutics? A short squeeze for Perspective Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CATX, which in turn drives the price of the stock up even further. How often is Perspective Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CATX, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: MDXG Short Interest AORT Short Interest FNA Short Interest KIDS Short Interest ATRI Short Interest ATRC Short Interest TMCI Short Interest SILK Short Interest SIBN Short Interest EMBC Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSEAMERICAN:CATX) was last updated on 4/30/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsAI finds its first serious applicationWall Street StarProtect Your Bank Account Before It’s Too LateWeiss RatingsHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportTruth about Trump you’ve never heardPorter & CompanyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold Group